journal article·2020-12-02

Silk Nanoparticles: A Natural Polymeric Platform for Nitric Oxide Delivery in Biomedical Applications

Sama Ghalei, Arnab Mondal, Sean Hopkins, Priyadarshini Singha, Ryan Devine, Hitesh Handa

ACS Applied Materials & Interfaces· Volume 12· Issue 48
Publisher page

Abstract

In this study, the preparation and characterization of nitric oxide (NO) releasing silk fibroin nanoparticles (SF NPs) are described for the first time. S-Nitroso-N-acetylpenicillamine (SNAP)-loaded SF NPs (SNAP-SF NPs) were prepared via an antisolvent/self-assembling method by adding a SNAP/ethanol solution to an aqueous SF solution and freeze-thawing. The prepared SNAP-SF NPs had a diameter ranging from 300 to 400 nm and an overall negative charge of −28.76 ± 0.73 mV. Among the different SNAP/SF ratios tested, the highest encapsulation efficiency (18.3 ± 1.3%) and loading capacity (9.1 ± 0.6%) values were attributed to the 1:1 ratio. The deconvolution of the amide I band in the FTIR spectra of SF NPs and SNAP-SF NPs showed an increase in the β-sheet content for SNAP-SF NPs, confirming the hydrophobic interactions between SNAP and silk macromolecules. SNAP-SF NPs released up to 1.31 ± 0.02 × 10–10 mol min–1 mg–1 NO over a 24 h period. Moreover, SNAP-SF NPs showed concentration-dependent antibacterial effects against methicillin-resistant Staphylococcus aureus and Escherichia coli. Furthermore, they did not elicit any marked cytotoxicity against 3T3 mouse fibroblast cells at concentrations equal to or below 2 mg/mL. Overall, these results demonstrated that SNAP-SF NPs have great potential to be used as a NO delivery platform for biomedical applications such as tissue engineering and wound healing, where synergistic properties of SF and NO are desired.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Silk-based biomaterials and applications · Electrospun Nanofibers in Biomedical Applications · Bone Tissue Engineering Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Chemical, Materials and Biomedical Engineering, University of Georgia, Athens, Georgia 30602, United States

Funding

University of Georgia

References (66)

Show source-provided references
1. 10.1016/j.bsbt.2015.08.00310.1016/j.bsbt.2015.08.003 ↗
2. 10.1016/j.biopha.2016.11.12510.1016/j.biopha.2016.11.125 ↗
3. 10.1038/s41598-017-14012-910.1038/s41598-017-14012-9 ↗
4. Liang H. · Future Sci. OA · 2015 · 110.4155/fso.15.54 ↗
5. 10.1002/jbm.b.3406510.1002/jbm.b.34065 ↗
6. 10.1039/c6bm00074f10.1039/c6bm00074f ↗
7. 10.1038/jid.2009.14910.1038/jid.2009.149 ↗
8. 10.1038/sj.bjp.070722410.1038/sj.bjp.0707224 ↗
9. Wang P. G. · 200510.1002/3527603751 ↗
10. 10.1002/adfm.20110170710.1002/adfm.201101707 ↗
11. 10.1021/acs.jpca.6b0223010.1021/acs.jpca.6b02230 ↗
12. 10.1016/j.biomaterials.2013.05.06310.1016/j.biomaterials.2013.05.063 ↗
13. 10.1016/j.niox.2004.09.00510.1016/j.niox.2004.09.005 ↗
14. 10.1111/j.1365-2133.2004.06213.x10.1111/j.1365-2133.2004.06213.x ↗
15. 10.1002/term.35310.1002/term.353 ↗
16. 10.1002/smll.20120045810.1002/smll.201200458 ↗
17. 10.1016/j.biomaterials.2004.06.00610.1016/j.biomaterials.2004.06.006 ↗
18. 10.1016/j.jconrel.2015.02.00710.1016/j.jconrel.2015.02.007 ↗
19. 10.1039/b912493b10.1039/b912493b ↗
20. 10.1016/j.jconrel.2015.12.05610.1016/j.jconrel.2015.12.056 ↗
21. 10.2174/15734131380511784810.2174/157341313805117848 ↗
22. 10.1002/jbm.a.3523910.1002/jbm.a.35239 ↗
23. 10.2147/IJN.S8219910.2147/IJN.S82199 ↗
24. 10.1080/15583724.2018.143754710.1080/15583724.2018.1437547 ↗
25. 10.1002/app.4664310.1002/app.46643 ↗
26. 10.1016/j.reactfunctpolym.2020.10450110.1016/j.reactfunctpolym.2020.104501 ↗
27. 10.3390/pharmaceutics1110049410.3390/pharmaceutics11100494 ↗
28. 10.1016/j.colsurfb.2018.08.02810.1016/j.colsurfb.2018.08.028 ↗
29. 10.1007/s10853-018-2635-310.1007/s10853-018-2635-3 ↗
30. 10.1016/j.ijpharm.2017.02.00510.1016/j.ijpharm.2017.02.005 ↗
31. 10.1039/c7sm01631j10.1039/c7sm01631j ↗
32. 10.1002/jbm.a.3653710.1002/jbm.a.36537 ↗
33. 10.1016/j.nano.2017.07.01210.1016/j.nano.2017.07.012 ↗
34. 10.1039/c7tb03113k10.1039/c7tb03113k ↗
35. 10.1021/acsbiomaterials.6b0045710.1021/acsbiomaterials.6b00457 ↗
36. 10.1021/acsbiomaterials.8b0045410.1021/acsbiomaterials.8b00454 ↗
37. 10.1021/acsami.6b1491210.1021/acsami.6b14912 ↗
38. 10.1016/j.biomaterials.2019.05.01210.1016/j.biomaterials.2019.05.012 ↗
39. 10.3390/antiox901008510.3390/antiox9010085 ↗
40. 10.3390/nano802012610.3390/nano8020126 ↗
41. 10.1080/1061186X.2017.136321210.1080/1061186X.2017.1363212 ↗
42. 10.1080/10717544.2020.173620810.1080/10717544.2020.1736208 ↗
43. 10.1016/j.jddst.2019.10129410.1016/j.jddst.2019.101294 ↗
44. 10.1038/nprot.2011.37910.1038/nprot.2011.379 ↗
45. 10.1021/acsami.7b0140810.1021/acsami.7b01408 ↗
46. 10.1039/b703139d10.1039/b703139d ↗
47. 10.1016/j.actbio.2018.04.02510.1016/j.actbio.2018.04.025 ↗
48. 10.1080/00914037.2018.155286110.1080/00914037.2018.1552861 ↗
49. 10.3390/ijms1603488010.3390/ijms16034880 ↗
50. 10.1002/jbm.a.3326510.1002/jbm.a.33265 ↗
51. 10.3390/ijms1712201210.3390/ijms17122012 ↗
52. 10.1021/acsami.5b0533510.1021/acsami.5b05335 ↗
53. 10.1016/j.actbio.2017.04.00110.1016/j.actbio.2017.04.001 ↗
54. 10.1074/jbc.271.31.1859610.1074/jbc.271.31.18596 ↗
55. Kevil C. G. · Curr. Opin. Invest. Drugs · 2010 · 11 · 1127
56. 10.1016/j.jconrel.2015.03.02010.1016/j.jconrel.2015.03.020 ↗
57. 10.1016/j.jconrel.2014.05.05910.1016/j.jconrel.2014.05.059 ↗
58. 10.1021/acsbiomaterials.7b0102110.1021/acsbiomaterials.7b01021 ↗
59. 10.1016/j.biomaterials.2010.09.05510.1016/j.biomaterials.2010.09.055 ↗
60. 10.1006/niox.1997.011810.1006/niox.1997.0118 ↗
61. 10.1016/j.jacc.2013.03.07010.1016/j.jacc.2013.03.070 ↗
62. 10.1016/j.actbio.2018.05.02510.1016/j.actbio.2018.05.025 ↗
63. 10.1093/toxsci/kft17910.1093/toxsci/kft179 ↗
64. 10.4161/viru.2032810.4161/viru.20328 ↗
65. 10.1016/j.actbio.2017.05.06110.1016/j.actbio.2017.05.061 ↗
66. 10.1016/j.actbio.2015.10.02110.1016/j.actbio.2015.10.021 ↗